INDIAN NEWS & TIMES

Saturday, December 3, 2022

Phable, India’s largest Chronic Disease Management App, unveiled insights from their recent clinical studies conducted for Hypertension and Type 2 Diabetes. The studies were presented at the BPCON Conference 2022 – Annual Meeting of Indian Society of Hypertension, Lucknow and at the RSSDI Conference 2022 – Annual Meeting of Research Society of the Study of Diabetes in India, Chennai.  

The studies established that digital therapeutics (DTx) intervention, applied through Phable’s proprietary algorithm and smartphone devices, helped chronic disease patients regain control of their health. 

Chronic diseases such as Type 2 Diabetes and Hypertension are called lifestyle diseases because their risk factors are linked to one᯳ way of living. The management of these conditions requires regular self-monitoring and behavior change, which seem like the easiest things to do but are difficult to stick to. Health-related behavior change needs consistency and constant nudging to become an implementable reality.  

Technology-driven behavior changes powered by Phable’s algorithm and applied through a smartphone can be the constant companion that chronic disease patients need. Using smartphones, wearables, and monitoring devices, patients can self-monitor their health parameters and report them to the Phable app. Phable᯳ proprietary algorithm takes in the health signals and suggests suitable actions to help drive behaviour change and treatment adherence in patients. Chronic disease patients can take control of their health with Phable, which is supported by the expertise of 17,000 doctors and the experience of helping 4.5 million Indians on their health journey.  

The advantages of adopting smartphone-enabled monitoring of chronic diseases are numerous and varied. Therefore, it needs to be adopted quickly by patients and doctors alike. Phable᯳ recent studies go on to establish the effectiveness of DTx in chronic disease ma